Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK)

Catalog No:
MBL-TS-M124-4
$1,575.00

Formerly Catalog No.: TB-M124-4

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence RVRAYTYSK
MHC Allele A*03:01

Documents & Links

Documents & Links for Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK)
Datasheet Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK) Datasheet

Documents & Links for Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK)
Datasheet Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK) Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation BV421
Peptide Sequence RVRAYTYSK
MHC Allele A*03:01

Documents & Links

Documents & Links for Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK)
Datasheet Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK) Datasheet

Documents & Links for Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK)
Datasheet Tetramer/BV421 - HLA-A*03:01  (20-28) EBV BRLF1 (RVRAYTYSK) Datasheet